0001437749-23-002338.txt : 20230202
0001437749-23-002338.hdr.sgml : 20230202
20230202130404
ACCESSION NUMBER: 0001437749-23-002338
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230131
FILED AS OF DATE: 20230202
DATE AS OF CHANGE: 20230202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Jason Drew
CENTRAL INDEX KEY: 0001821479
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 23579829
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 400 ALEXANDER PARK DRIVE
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
rdgdoc.xml
FORM 4
X0306
4
2023-01-31
0001668243
UroGen Pharma Ltd.
URGN
0001821479
Smith Jason Drew
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
General Counsel
Ordinary Shares
2023-01-31
4
M
0
833
A
13009
D
Ordinary Shares
2023-01-31
4
S
0
409
10.12
D
12600
D
Ordinary Shares
2023-01-31
4
M
0
2500
A
15100
D
Ordinary Shares
2023-01-31
4
S
0
1227
10.12
D
13873
D
Restricted Stock Units
2023-01-31
4
M
0
833
0
D
Ordinary Shares
833
834
D
Restricted Stock Units
2023-01-31
4
M
0
2500
0
D
Ordinary Shares
2500
5000
D
Restricted Stock Units
2023-01-31
4
A
0
20000
0
A
Ordinary Shares
20000
20000
D
Employee Stock Option (right to buy)
10.39
2023-01-31
4
A
0
40000
0
A
2033-01-31
Ordinary Shares
40000
40000
D
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022.
The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023.
1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026.
1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026.
/s/ Jason D. Smith, Attorney-in-Fact
2023-02-02